Objective: This study investigated the incidence and clinical relevance of the slow-flow phenomenon after infrapopliteal balloon angioplasty.
Critical limb ischemia (CLI) remains a challenging issue in patients with peripheral artery disease. Most patients with CLI have multisegmental disease involving the infrapopliteal arteries, and limb salvage is the primary goal of treatment for CLI. Endovascular treatment (EVT) has become commonplace as a first-line treatment strategy because of its achievement of acceptable clinical outcomes in patients with severe CLI who present with comorbidities such as heart failure. [1] [2] [3] [4] [5] The European Society of Cardiology guideline recommends primary angioplasty as a standard treatment for CLI because of its acceptable outcomes and low procedural cost. 6, 7 However, the guideline also adds that stent implantation in infrapopliteal vessels is generally reserved for patients with suboptimal outcomes after percutaneous transluminal angioplasty (PTA). If we cannot use drug-eluting stents or bare-metal stents for infrapopliteal lesions, we sometimes experience the no-reflow or slow-flow phenomenon after balloon angioplasty for the infrapopliteal artery in the clinical setting. In the area of coronary artery intervention, several studies demonstrated that the no-reflow or slow-flow phenomenon after percutaneous coronary intervention was associated with poor functional recovery and adverse clinical events because of its microvascular dysfunction. [8] [9] [10] [11] [12] [13] [14] No-reflow phenomenon after infrapopliteal angioplasty is regarded as an unsuccessful EVT, but we do not know whether the slow-flow phenomenon after infrapopliteal angioplasty leads to the same result. In Japan, stent implantation for infrapopliteal vessels is not allowed by the Ministry of Health, and we must stop EVT even in patients with slow flow. To date, we do not know the incidence and clinical outcomes of the slow-flow phenomenon after PTA for infrapopliteal vessels. This study aimed to clarify the incidence and clinical outcomes of the slowflow phenomenon after infrapopliteal angioplasty.
METHODS
Study design and patients. This was a single-center, retrospective study. Between April 2012 and May 2015 at Saiseikai Yokohama City Eastern Hospital, 338 consecutive limbs were subjected to EVT for infrapopliteal lesions. Of these limbs, 105 limbs were excluded because of unsuccessful EVT, acute limb ischemia, Rutherford class 4, and repeated EVT for infrapopliteal arteries. Thus, 161 consecutive patients (173 limbs) were enrolled in this study. Of these limbs, 12 patients suffered from bilateral limb ischemia, and the patients were enrolled only at the initial EVT. On the basis of angiographic findings on final angiography, the patients were divided into slow-flow and no-slow-flow groups (Fig 1) .
The incidence of slow flow and clinical outcomes (freedom from major amputation and cumulative incidence of wound healing at 2 years) were compared between the two groups. This strategy is in accordance with the guidelines for epidemiologic studies issued by the Ministry of Health, Labor, and Welfare of Japan. The study protocol was approved by the Institutional Review Board of Saiseikai Yokohama City Eastern Hospital. Because of the retrospective enrollment, the requirement for obtaining written informed consent from patients was waived.
Intervention. The indication and strategy for EVT were decided by consensus among vascular surgeons and interventional cardiologists, depending on the patient's general condition, comorbidities, and lower limb severity. Patients with a life expectancy >2 years and those with CLI (Rutherford class 6) and good autogenous veins (diameter >3 cm) were commonly selected for primary surgical bypass therapy.
All concomitant aortoiliac or femoropopliteal lesions were treated before infrapopliteal intervention. Selection of the puncture site and the method of endovascular recanalization were determined by the operators on the basis of the clinical conditions and endovascular strategy. In cases of multisegment disease, the interval between suprapopliteal (aortoiliac and femoropopliteal) and infrapopliteal interventions was also left to the operators' discretion. Following confirmatory diagnostic angiography, catheter-based treatment was implemented with all procedures performed under local anesthesia. When an ipsilateral antegrade femoral approach was employed, a 4F sheath, 4.5F parent sheath, or 6F sheath was placed. When a contralateral femoral approach was employed, a 6F SheathLess PV (Asahi Intec, Aichi, Japan) or 6F Destination (Terumo, Tokyo, Japan) guide catheter was used. After insertion of the sheath, unfractionated heparin (5000 units) was routinely administered into the artery, with additional heparin given intravenously during the procedure to maintain the activated clotting time at >200 seconds. A 0.014-inch guidewire was advanced into the culprit lesion and dilated using an optimally sized balloon catheter at the operator's discretion. Antiplatelet therapy with aspirin (100 mg daily) and clopidogrel (75 mg daily) or cilostazol (100 mg twice daily) was started at least 1 week before EVT and continued for life if possible.
Our EVT strategy was to provide visible blood supply to the wounds regardless of the blood flow according to the angiosome concept with an intimal approach.
Before the endovascular intervention, the location of the nonhealing ulceration/gangrene was confirmed, and the angiosome-based favorable target lesion was assessed by digital angiography (DA). Angiosomeoriented arterial recanalization was first attempted. Visible blood supply was evaluated immediately after EVT to determine whether any visible blood flow reaching the same position of the wound was achieved. However, if treatment of the angiosome-based target lesions was unsuccessful, a non-angiosome-oriented lesion through a collateral network was treated when blood flow to the wound was insufficient.
Follow-up and wound management. All patients were followed up at our outpatient foot care clinic once or twice a week until wound healing. Wound status evaluation and wound care management were decided by our foot care team, which consisted of cardiologists, plastic surgeons, and nurses specialized in foot care training. We evaluated and managed the ulcer using the TIME concept during follow-up. 15 TIME is an acronym for the following: T, tissue; I, infection or inflammation; M, moisture imbalance; and E, edge of wound (nonadvancing or undermined). The severity of wounds, especially of infected wounds, was carefully assessed by our team, which determined the indication for antibiotic therapy and amputation timing. Ulcer status and time to complete healing were recorded. Ankle-brachial index, skin perfusion pressure (SPP), and duplex ultrasound imaging were performed to assess the status of ischemia when wound healing was delayed. We did not perform routine duplex ultrasound imaging or angiography if wound healing was favorable. If a patient did not return to the hospital, limb status and his or her general health were checked by a phone interview. There were eight patients who were followed up with a phone interview because of transfer to different hospitals.
Definition of the slow-flow phenomenon. The slowflow phenomenon was defined as delayed or sluggish antegrade flow with complete filling of the distal territory of the foot after infrapopliteal angioplasty regardless of direct flow to the wounds. To objectively evaluate an index of blood flow of the lower extremity as a continuous quantitative variable, the number of cine frames required for contrast material to first reach the ankle joint was measured with a frame count on the Medica cine viewer (Gadelius, Tokyo, Japan). The first frame used for frame counting is the first frame in which dye fully enters proximal of the infrapopliteal artery. This occurs when three criteria are met: (1) a column of nearly full or fully concentrated dye must extend across the entire width of the origin of the artery; (2) dye must touch each border of the origin of the anterior tibial artery, peroneal artery, and posterior tibial artery; and (3) there must be antegrade motion to the dye. The last frame is counted or included as one of the frames and is defined as the frame when dye first enters the distal ankle joint.
The slow-flow phenomenon was judged by final DA in two different angles after infrapopliteal angioplasty. Final DA was performed with 10 mL of contrast material at the distal popliteal artery position of the sheath. The strength of the contrast agent injection was fixed with 4 to 5 mL/s to fill the distal territory completely by experienced EVT operators. The frame rate of a digital blood flow of the lower extremity image was calculated as 7.5 frames/s. The frame counts of the lower extremity artery blood flow of the enrolled 161 patients in our facility were obtained to determine the average frame count. The mean frame count value obtained from these subjects was 35. Therefore, a cutoff point of 35 was used to divide blood flow of lower extremity slow flow vs no slow. Assessment of frame count was made by two experienced observers blinded to other clinical data. Disagreement was resolved by a third observer. When we performed EVT for more than two vessels and the slowflow phenomenon occurred at least in one vessel, the limb was included in the slow-flow group.
Definitions. Ischemic tissue loss was defined in accordance with TransAtlantic Inter-Society Consensus as tissue loss associated with an ankle pressure of <70 mm Hg or toe pressure of <50 mm Hg. 16 When these measurements could not be obtained, SPP was measured. SPP of <40 mm Hg indicated ischemic tissue loss. 17, 18 Major amputation means above-the-ankle amputation. Wound healing was defined as the achievement of complete epithelialization of all wounds without major amputation. Healing time was defined as the time elapsed from initial EVT to complete epithelialization.
Patients who died before wound healing was achieved were considered to have delayed wound healing, with the date of death used as the cutoff date. In patients who underwent major amputation, the healing time was considered to be infinite. Wounds were classified according to the Rutherford classification. Rutherford class 5 denotes minor tissue loss (nonhealing ulcer, focal gangrene with diffuse pedal ischemia). Rutherford class 6 denotes major tissue loss (extending above the transmetatarsal level of the functional foot, limb no longer salvageable, or lesion located at the heel). 19 Successful EVT was defined as success in crossing the lesion with the guidewire and ballooning. Unsuccessful EVT was defined as a failure to cross the lesion with the guidewire, failure to deliver the balloon to the lesion, and no flow after infrapopliteal ballooning.
Direct EVT referred to successful revascularization based on direct wound flow with DA but not based on the angiosome concept. Visible blood flow to the wounds was documented by DA immediately after EVT without relation to the angiosome concept.
Severe calcification was defined as obvious calcification without contrast agent at the site of intervention.
Infection was defined as the use of antibiotics during the course of the disease, excluding prophylactic purposes.
Postpedal arch was defined as the main contralateral pedal artery, through the connection by the deep penetrating artery and not necessarily the entire pedal-plantar loop.
Statistical analysis. Statistical analysis was performed using JMP version 10.0.2 (SAS Institute, Cary, NC). Data are presented as values and percentages, mean 6 standard deviation, or median (interquartile range). Categorical variables were compared between groups using the c 2 test or Fisher exact test, as appropriate. Continuous variables were compared between the groups using the Mann-Whitney U test.
Clinical and angiographic variables and additional nonsignificant variables with potential clinical importance were analyzed using a univariate Cox proportional hazards model for major amputation and wound healing. The cumulative rates of wound healing and amputation-free survival were compared using the Kaplan-Meier method evaluated with the log-rank test. P < .05 was considered statistically significant.
RESULTS
Patient, lower limb, and lesion characteristics and intervention results. The baseline patient characteristics are shown in Table I . There were no significant differences between the slow-flow and no-slow-flow groups.
The patients' lower limb characteristics are shown in Table II . There were no significant differences between the two groups. A posterior tibial artery, severe calcification, and total occlusion were more common in the slow-flow group than in the no-slow-flow group (50% vs 30% [P ¼ .02]; 43% vs 8% [P < .01]; and 90% vs 63% [P < .01], respectively). There were no significant differences between the two groups in blood flow to the wounds, angiosome, final balloon size, final ballooning time, and runoff vessels. Postpedal arch was more frequently observed in the no-slow-flow group (30% vs 7%; P < .01; Table III) .
Prognosis of CLI after the slow-flow phenomenon. The overall average follow-up period was 414 6 322 days.
The rates of wound healing in the no-slow-flow group were 77.2% and 91.2% at 1 year and 2 years after EVT, respectively. The wound healing rates were worse in the slow-flow group than in the no-slow-flow group (1-year wound healing rate, 57%; 2-year wound healing rate, 77%; both P ¼ .03; Fig 2) .
The amputation-free rate was significantly lower in the slow-flow group (1-year amputation-free rate, 60% vs 88%; 2-year amputation-free rate, 60% vs 86%; both P < .01; Fig 3) .
Predictors of wound healing and major amputation. Univariate Cox proportional hazard analysis identified Rutherford class 6, the slow-flow phenomenon, and postpedal arch as independent predictors of wound healing (Table IV) .
Univariate Cox proportional hazard analysis also identified Rutherford class 6, the slow-flow phenomenon, and hemodialysis as predictors of major amputation (Table V) .
DISCUSSION
The main findings of this study were as follows:
1. The incidence of the slow-flow phenomenon after infrapopliteal angioplasty was 18.6%. 2. The slow-flow phenomenon after infrapopliteal angioplasty might be associated with lower wound healing rates and major amputation compared with the absence of slow flow.
CLI remains a critical disease because of its associations with decreased quality of life and walking ability as well Continuous data are presented as the mean 6 standard deviation; categorical data are given as the number (%). as high amputation and poor survival rates. We reported that wound healing results in better clinical outcomes. 20 Conte et al suggested objective performance goals and clinical trial design as some of the goals for treating CLI. 21 However, we believe that avoiding major amputation and achieving wound healing are associated with an improved clinical course in patients with CLI. As a major premise, blood flow to the wound is necessary to achieve wound healing. EVT for infrapopliteal lesions has been proposed as the first-line treatment for revascularization, even in patients with other complications.
22,23
On the contrary, bypass surgery for infrapopliteal lesions should be considered if EVT fails or the patient's life expectancy is >2 years. 24, 25 In EVT for infrapopliteal lesions, drug-eluting stent implantation has been increasingly used because of its better patency compared with PTA and bare-metal stents. 7, 9, 15, [26] [27] [28] [29] [30] [31] [32] Drug-eluting balloons are another treatment, but efficacy remains controversial. 33, 34 In Japan, we are not allowed to use drugeluting stents or drug-eluting balloons for infrapopliteal lesions, and although technical success is achieved, the slow-flow phenomenon after EVT for infrapopliteal angioplasty sometimes occurs because of heterogeneity of the patients. In this retrospective analysis, the slowflow phenomenon incidence was 18.6%. In the slowflow group, severe calcification and total occlusion were frequently observed. This finding suggests that severe calcification and total occlusion might increase the difficulty of the EVT procedure, and consequently, subintimal angioplasty, dissection after ballooning, and distal embolization occur as main reasons of slow flow.
As another reason, acute recoil, microvascular dysfunction, and worsening of limb condition, such as major tissue loss, might be other factors. In this analysis, a low ejection fraction might not be associated with the slow-flow phenomenon. In our clinical setting, more than half of patients with CLI are undergoing regular hemodialysis. In addition, most patients had diabetes mellitus. These comorbidities might cause infrapopliteal lesions to become severely calcified. In other countries, the incidence of the slow-flow phenomenon after infrapopliteal angioplasty might be lower because there are fewer patients undergoing regular hemodialysis. Most important, this study focused on the wound healing and major amputation rates in patients with the slow-flow phenomenon after infrapopliteal angioplasty. The rates of wound healing and major amputation were significantly lower in the slow-flow group than in the no-slow-flow group in this study because the slow-flow phenomenon after infrapopliteal angioplasty implies incomplete revascularization and blood flow to heal the wounds even if there is blood flow with complete filling of the distal territory after infrapopliteal angioplasty.
In the coronary intervention area, the slow-flow phenomenon was regarded as failure to achieve adequate tissue perfusion, and at the time of reperfusion, microcirculatory damage induced by ischemia was one of the causes of poor outcomes. [8] [9] [10] [11] [12] [13] [14] These mechanisms might be applied to the slow-flow phenomenon after infrapopliteal angioplasty. A recent study illustrated that additional pedal artery angioplasty might improve wound healing, and in the study, a final pedal arch was the predictor of wound healing. 35 In the slow-flow group, a pedal arch was not frequently observed; this result implied that slow flow may result in an insufficient pedal arch, and lower wound healing rates were observed. Although the angiosome concept is one of the end points after EVT of infrapopliteal arteries for treating CLI, another study reported that the angiosome concept did not affect limb salvage. [36] [37] [38] In our institution, the strategy of EVT in infrapopliteal angioplasty for CLI is direct flow to the wounds regardless of the angiosome concept. There was no difference between the two groups regarding achievement of the angiosome concept, and this result might be associated with our EVT strategy for infrapopliteal angioplasty.
In the case of slow flow, this study demonstrated that the limb status might be worsened compared with that before EVT. The slow-flow phenomenon results in poor limb prognosis because of the incomplete blood flow to the wounds.
If the slow-flow phenomenon occurs during the EVT procedure, additional long ballooning and thrombectomy should be considered to avoid the slow-flow phenomenon. As another method, pharmacologic treatments, such as prostaglandin E 1 or nicorandil, might be effective to achieve sufficient flow to the wounds or to improve microvascular dysfunction. The previous studies demonstrated that these treatments attenuated microvascular dysfunction and augmented blood flow in the coronary intervention area. 39, 40 This mechanism might be applicable to the slow-flow phenomenon in the peripheral artery area. If these methods are not effective and the limb condition is worsened compared with that before EVT, bypass surgery should be considered to avoid poor outcomes, considering the patient's general condition and condition of the vessels for connecting the bypass.
Study limitations. There are several important limitations to consider in this study.
First, this was a single-center, retrospective study that included only Japanese patients with CLI, a high proportion of whom were receiving dialysis. Therefore, this result may not be extrapolated to other populations.
Second and most important, the number of limbs with slow flow was too small to investigate the risk factors of slow flow and to evaluate possible correlations with wound healing and major amputation. The real incidence, risk factors, and clinical outcomes of slow flow should be evaluated in a larger number of patients.
Third, new devices, including drug-eluting balloons, drug-eluting stents, and atherectomy devices, were not approved in Japan during the study period. There was little heterogeneity in treatment strategies.
CONCLUSIONS
The slow-flow phenomenon occurred after infrapopliteal balloon angioplasty in 18.6% of limbs. The slowflow phenomenon may result in poor outcomes. 
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